Glimepiride
Top View
- Comparative Safety and Efficacy of Glibenclamide in the Elderly
- Package Leaflet: Information for the Patient Glimepiride Mylan 1 Mg
- Medication Overdoses in the Emergency Department: Oral Hypoglycemic Agents, Atypical Antipsychotic Agents, Beta- Blockers, Calcium Channel Blockers, and Digoxin
- (12) Patent Application Publication (10) Pub. No.: US 2014/0221286 A1 Belardinelli Et Al
- Rifamycins and Anti-Diabetic Agents: Drug-Drug Interactions
- What's the Latest on Sulphonylureas in the Management of Type 2 Diabetes?
- Management of Diabetes Before and After Surgery Or Procedure
- Identification of Drug Candidates That Enhance Pyrazinamide Activity from a Clinical Drug Library
- Tablet Splitting Commonly Asked Questions NPS
- Identification of Drug Candidates That Enhance Pyrazinamide Activity from a Clinical Drug Library
- Incidence of Hypoglycemia and Other Side Effects in Patients of Type 2 Diabetes Mellitus Treated with Glimepiride Versus Glibenclamide
- WO 2013/043925 Al © FIG. 14
- AVANDARYL™ (Rosiglitazone Maleate and Glimepiride) Tablets
- Amaryl (Glimepiride)
- “Comparative In-Vitro Evaluation of Glimepiride Nanosuspension Prepared by Different Techniques”
- Overview of the Antidiabetic Agents
- Diabetes Medications Dosing Guide
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances